ARCHIVES

Novel Antifungal Agent Highly Active Against Esophageal Candidiasis

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

December 29, 2006

In Brief: President’s Request For NCI FY 1981 Budget: Same As 1980; New Clinical Study Section Option Open

December 14, 1979

U.S., Canada To Collaborate On Indian Health Services.

May 17, 2002

NCI Outlines Need For $3,873 Billion To Seize Cancer Research Opportunities

October 30, 1998

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

July 30, 2004